PYC Therapeutics Limited (PYC.AX)
AUD 1.41
(-6.0%)
AUD 1.41
(-6.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 22.05 Million AUD | 47.81% |
| 2023 | 14.92 Million AUD | -1.84% |
| 2022 | 15.2 Million AUD | 520.04% |
| 2021 | 2.45 Million AUD | 32.64% |
| 2020 | 1.84 Million AUD | 1515.94% |
| 2019 | -130.55 Thousand AUD | -297.58% |
| 2018 | -32.83 Thousand AUD | 98.28% |
| 2017 | -1.9 Million AUD | -1477.4% |
| 2016 | -121.03 Thousand AUD | 95.6% |
| 2015 | -2.74 Million AUD | 4.54% |
| 2014 | -2.88 Million AUD | -12.73% |
| 2013 | -2.55 Million AUD | -233.18% |
| 2012 | 1.91 Million AUD | -18.66% |
| 2011 | 2.35 Million AUD | 295.56% |
| 2010 | 596.25 Thousand AUD | -53.23% |
| 2009 | 1.27 Million AUD | 1304.86% |
| 2008 | 90.75 Thousand AUD | 3041.29% |
| 2007 | 2889.00 AUD | 102.11% |
| 2006 | -137.23 Thousand AUD | -361.12% |
| 2005 | 52.55 Thousand AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | -1.06 Million AUD | -107.15% |
| 2024 Q2 | 8.57 Million AUD | 0.0% |
| 2024 Q4 | 12.42 Million AUD | 0.0% |
| 2023 Q4 | 12.24 Million AUD | 0.0% |
| 2023 FY | 14.92 Million AUD | -1.84% |
| 2023 Q2 | 3.01 Million AUD | 0.0% |
| 2022 FY | 15.2 Million AUD | 520.04% |
| 2022 Q4 | 9.63 Million AUD | 0.0% |
| 2022 Q2 | 5.57 Million AUD | 0.0% |
| 2021 FY | 2.45 Million AUD | 32.64% |
| 2021 Q2 | -286.99 Thousand AUD | 0.0% |
| 2021 Q4 | 2.73 Million AUD | 0.0% |
| 2020 Q4 | 2.09 Million AUD | 0.0% |
| 2020 FY | 1.84 Million AUD | 1515.94% |
| 2020 Q2 | -241.75 Thousand AUD | 0.0% |
| 2019 Q4 | -90.68 Thousand AUD | 0.0% |
| 2019 FY | -130.55 Thousand AUD | -297.58% |
| 2019 Q2 | -2.84 Million AUD | 0.0% |
| 2018 Q2 | -2.88 Million AUD | 0.0% |
| 2018 FY | -32.83 Thousand AUD | 98.28% |
| 2018 Q4 | -4.03 Million AUD | 0.0% |
| 2017 Q4 | -2.45 Million AUD | 0.0% |
| 2017 FY | -1.9 Million AUD | -1477.4% |
| 2017 Q2 | 542.99 Thousand AUD | 0.0% |
| 2016 Q2 | -1.9 Million AUD | 0.0% |
| 2016 FY | -121.03 Thousand AUD | 95.6% |
| 2016 Q4 | -2.5 Million AUD | 0.0% |
| 2015 Q2 | -1.03 Million AUD | 0.0% |
| 2015 FY | -2.74 Million AUD | 4.54% |
| 2015 Q4 | -1.71 Million AUD | 0.0% |
| 2014 Q2 | -982.69 Thousand AUD | 0.0% |
| 2014 Q4 | -1.89 Million AUD | 0.0% |
| 2014 FY | -2.88 Million AUD | -12.73% |
| 2013 Q3 | - AUD | 100.0% |
| 2013 Q2 | -1.47 Million AUD | -407.77% |
| 2013 Q1 | 479.59 Thousand AUD | 0.0% |
| 2013 FY | -2.55 Million AUD | -233.18% |
| 2013 Q4 | -1.07 Million AUD | 0.0% |
| 2012 Q4 | 479.59 Thousand AUD | 0.0% |
| 2012 Q2 | 479.59 Thousand AUD | -18.66% |
| 2012 Q3 | 479.59 Thousand AUD | 0.0% |
| 2012 FY | 1.91 Million AUD | -18.66% |
| 2012 Q1 | 589.63 Thousand AUD | 0.0% |
| 2011 FY | 2.35 Million AUD | 295.56% |
| 2011 Q2 | 589.63 Thousand AUD | 295.56% |
| 2011 Q3 | 589.63 Thousand AUD | 0.0% |
| 2011 Q4 | 589.63 Thousand AUD | 0.0% |
| 2011 Q1 | 149.06 Thousand AUD | 0.0% |
| 2010 Q1 | 318.73 Thousand AUD | 0.0% |
| 2010 FY | 596.25 Thousand AUD | -53.23% |
| 2010 Q4 | 149.06 Thousand AUD | 0.0% |
| 2010 Q2 | 149.06 Thousand AUD | -53.23% |
| 2010 Q3 | 149.06 Thousand AUD | 0.0% |
| 2009 Q1 | 22.68 Thousand AUD | 0.0% |
| 2009 Q2 | 318.73 Thousand AUD | 1304.86% |
| 2009 Q3 | 318.73 Thousand AUD | 0.0% |
| 2009 FY | 1.27 Million AUD | 1304.86% |
| 2009 Q4 | 318.73 Thousand AUD | 0.0% |
| 2008 Q4 | 22.68 Thousand AUD | 0.0% |
| 2008 FY | 90.75 Thousand AUD | 3041.29% |
| 2008 Q1 | 722.25 AUD | 0.03% |
| 2008 Q2 | 22.68 Thousand AUD | 3041.29% |
| 2008 Q3 | 22.68 Thousand AUD | 0.0% |
| 2007 Q3 | 722.25 AUD | 0.03% |
| 2007 FY | 2889.00 AUD | 102.11% |
| 2007 Q4 | 722.00 AUD | -0.03% |
| 2007 Q2 | 722.00 AUD | 102.1% |
| 2007 Q1 | -34.3 Thousand AUD | 0.0% |
| 2006 Q4 | -34.3 Thousand AUD | 0.0% |
| 2006 Q2 | -34.3 Thousand AUD | -361.12% |
| 2006 Q3 | -34.3 Thousand AUD | 0.0% |
| 2006 FY | -137.23 Thousand AUD | -361.12% |
| 2006 Q1 | 13.13 Thousand AUD | 0.0% |
| 2005 Q3 | 13.13 Thousand AUD | 0.0% |
| 2005 Q2 | 13.13 Thousand AUD | 0.0% |
| 2005 FY | 52.55 Thousand AUD | 0.0% |
| 2005 Q4 | 13.13 Thousand AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 50.94 Million AUD | 56.7% |
| Anatara Lifesciences Ltd | -748.91 Thousand AUD | 3045.523% |
| Zelira Therapeutics Limited | 10.28 Thousand AUD | -214401.303% |
| Biome Australia Limited | 7.66 Million AUD | -187.618% |
| Patrys Limited | 1.39 Million AUD | -1482.262% |
| Orthocell Limited | 3.68 Million AUD | -498.069% |
| Imugene Limited | -5.83 Million AUD | 477.738% |
| Noxopharm Limited | -534.81 Thousand AUD | 4224.693% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | -195.95% |
| Prescient Therapeutics Limited | 3.71 Million AUD | -494.212% |
| Proteomics International Laboratories Limited | -1.12 Million AUD | 2063.989% |
| Cynata Therapeutics Limited | 2.31 Million AUD | -852.622% |
| CSL Limited | 15.28 Billion AUD | 99.856% |
| Arovella Therapeutics Limited | -25.97 Thousand AUD | 85012.098% |
| Bio-Gene Technology Limited | -301.44 Thousand AUD | 7417.76% |
| Clinuvel Pharmaceuticals Limited | 78.09 Million AUD | 71.754% |
| Starpharma Holdings Limited | 7.65 Million AUD | -188.093% |
| Nanollose Limited | -348.95 Thousand AUD | 6421.59% |
| Memphasys Limited | 1606.00 AUD | -1373456.289% |
| Invex Therapeutics Ltd | 1.21 Million AUD | -1719.691% |
| NeuroScientific Biopharmaceuticals Limited | -91.33 Thousand AUD | 24251.564% |
| Amplia Therapeutics Limited | 4.01 Million AUD | -450.004% |
| Botanix Pharmaceuticals Limited | -6.55 Million AUD | 436.704% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | -1662.524% |
| Race Oncology Limited | 1.38 Million AUD | -1487.098% |
| Nyrada Inc. | -5164.07 AUD | 427269.151% |
| Telix Pharmaceuticals Limited | 308.5 Million AUD | 92.85% |
| Dimerix Limited | 583.47 Thousand AUD | -3680.659% |
| PharmAust Limited | -1641.00 AUD | 1344360.451% |
| Immutep Limited | 1.44 Million AUD | -1427.755% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | -91.709% |
| Alterity Therapeutics Limited | 3.8 Million AUD | -479.748% |
| BTC Health Limited | 16.36 Thousand AUD | -134736.883% |
| Acrux Limited | -1.28 Million AUD | 1818.015% |
| Neuren Pharmaceuticals Limited | 205.17 Million AUD | 89.248% |
| Biotron Limited | -40.49 Thousand AUD | 54570.132% |
| Tissue Repair Ltd | 150.51 Thousand AUD | -14556.28% |
| AdAlta Limited | 1.5 Million AUD | -1362.902% |
| Radiopharm Theranostics Limited | -21.3 Million AUD | 203.525% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 460.39 Thousand AUD | -4691.368% |
| Paradigm Biopharmaceuticals Limited | 56.81 Thousand AUD | -38728.617% |
| Recce Pharmaceuticals Ltd | -366.76 Thousand AUD | 6114.514% |
| Avecho Biotechnology Limited | -43.79 Thousand AUD | 50469.481% |
| Actinogen Medical Limited | 9.93 Million AUD | -122.115% |
| Immuron Limited | 3.33 Million AUD | -561.092% |
| Argenica Therapeutics Limited | 2.59 Million AUD | -749.109% |